Multiple pathologies in a patient with a progressive neurodegenerative syndrome

Journal of Neurology, Neurosurgery and Psychiatry

Volumn 76, Issue 2, 2005, Pages 252-255

  Liang, Tsao Wei ^a,b   Forman, M S ^a   Duda, J E ^a   McCluskey, L ^a   Trojanowski, J Q ^a   Siderowf, A ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA SYNUCLEIN; LEVODOPA; TAU PROTEIN; UBIQUITIN;

ADULT; AMYOTROPHIC LATERAL SCLEROSIS; ARGYROPHILIA; ARGYROPHILIC GRAIN DISEASE; ARTICLE; AUTOPSY; BULBAR PARALYSIS; CASE REPORT; CLINICAL FEATURE; DEGENERATIVE DISEASE; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MOTOR NEURON DISEASE; NERVE DEGENERATION; NEUROLOGIC DISEASE; PARKINSON DISEASE; PARKINSONISM; PRIORITY JOURNAL; PROTEIN AGGREGATION; QUADRIPLEGIA;

AMYOTROPHIC LATERAL SCLEROSIS; AUTOPSY; BRAIN DISEASES; COMORBIDITY; FEMALE; HUMANS; MIDDLE AGED; PARKINSON DISEASE; TAU PROTEINS;

EID: 12444339503     PISSN: 00223050     EISSN: None     Source Type: Journal    
DOI: 10.1136/jnnp.2004.039479     Document Type: Article

References (27)

1. Rodgers-Johnson P, Garruto RM, Yanagihara R, et al. Amyotrophic lateral sclerosis and parkinsonism-dementia on Guam: a 30-year evaluation of clinical and neuropathologic trends. Neurology 1986;36:7-13.
2. Konagoya M, Kato T, Sakai M, et al. A clinical and pathological study of a Japanese case of amyotrophic lateral sclerosis/parkinsonism-dementia complex with family history. J Neurol 2003;250:164-70.
3. Zoccolella S, Palagano G, Fraddosio A, et al. ALS-plus: 5 cases of concomitant amyotrophic lateral sclerosis and parkinsonism. Neurol Sci 2002;23(suppl 2):S123-4.
4. Judkins AR, Forman MS, Uryu K, et al. Co-occurrence of Parkinson's disease with progressive supranuclear palsy. Acta Neuropathol (Berl) 2002;103:526-30.
5. Takanashi M, Ohta S, Matsuoka S, et al. Mixed multiple system atrophy and progressive supranuclear palsy: a clinical and pathological repart of one case. Acta Neuropathol (Berl) 2002;103:82-7.
6. Testa D, Tiranti V, Girotti F. Unusual association of sporadic olivopontocerebellar atrophy and motor neuron disease. Neurol Sci 2002;23:243-5.
7. Hedera P, Lerner AJ, Castellani R, et al. Concurrence of Alzheimer's disease, Parkinson's disease, diffuse Lewy body disease, and amyotrophic lateral sclerosis. J Neurol Sci 1995;128:219-24.
8. Greenberg SG, Davies P. A preparation of Alzheimer paired helical filaments that displays distinct tau proteins by polyacrylamide gel electrophoresis. Proc Natl Acad Sci USA 1990;87:5827-31.
9. Giasson BI, Duda JE, Murray IV, et al. Oxidative damage linked to neurodegeneration by selective alpha-synuclein nitration in synucleinopathy lesions. Science 2000;290:985-9.
10. Jellinger KA. Dementia with grains (argyrophilic grain disease). Brain Pathol 1998;8:377-86.
11. Braak H, Braak E. Argyrophilic grains: characteristic pathology of cerebral cortex in cases of adult onset dementia without Alzheimer changes. Neurosci Lett 1987;76:124-7.
12. Lee VM, Goedert M, Trojanowski JQ. Neurodegenerative tauopathies. Annu Rev Neurosci 2001;24:1121-59.
13. Ferrer I, Barrachina M, Tolnay M, et al. Phosphorylated protein kinases associated with neuronal and glial tau deposits in argyrophilic grain disease. Brain Pathol 2003;13:62-78.
14. Togo T, Sahara N, Yen SH, et al. Argyrophilic grain disease is a sporadic 4-repeat tauopathy. J Neuropathol Exp Neurol 2002;61:547-56.
15. Zhukareva V, Shah K, Uryu K, et al. Biochemical analysis of tau proteins in argyrophilic grain disease, Alzheimer's disease, and Pick's disease: a comparative study. Am J Pathol 2002;161:1135-41.
16. Tolnay M, Spillantini MG, Goedert M, et al. Argyrophilic grain disease: widespread hyperphosphorylation of tau protein in limbic neurons. Acta Neuropathol (Berl) 1997;93:477-84.
17. Martinez-Lage P, Munoz DG. Prevalence and disease associations of argyrophilic grains of Braak. J Neuropathol Exp Neurol 1997;56:157-64.
18. Braak H, Braak E. Argyrophilic grain disease: frequency of occurrence in different age categories and neuropathological diagnostic criteria. J Neural Transm 1998;105:801-19.
19. Togo T, Cookson N, Dickson DW. Argyrophilic grain disease: neuropathology, frequency in a dementia brain bank and lack of relationship with apolipoprotein E. Brain Pathol 2002;12:45-52.
20. Ikeda K, Akiyama H, Kondo H, et al. A study of dementia with argyrophilic grains. Possible cytoskeletal abnormality in dendrospinal portion of neurons and oligodendroglia. Acta Neuropathol (Berl) 1995;89:409-14.
21. Tolnay M, Schwietert M, Monsch AU, et al. Argyrophilic grain disease: distribution of grains in patients with and without dementia. Acta Neuropathol (Berl) 1997;94:353-8.
22. Forman MS, Schmidt ML, Kasturi S, et al. Tau and alpha-synuclein pothology in amygdala of Parkinsonism-dementia complex patients of Guam. Am J Pathol 2002;160:1725-31.
23. Duda JE, Giasson BI, Mobon ME, et al. Concurrence of alpha-synuclein and tau brain pathology in the Contursi kindred. Acta Neuropathol (Berl) 2002;104:7-11.
24. Giasson BI, Forman MS, Higuchi M, et al. Initiation and synergistic fibrillizatian of tau and alpha-synuclein. Science 2003;300:636-40.
25. Giasson BI, Lee VM. Are ubiquitin pathways central to Parkinson's disease? Cell 2003;114:1-8.
26. Ischiropoulos H, Beckman JS. Oxidative stress and nitration in neurodegeneration: cause, effect, or association? J Clin Invest 2003;111:163-9.
27. Hyun DH, Lee M, Halliwell B, et al. Proteasamal inhibition causes the formation of protein aggregates containing a wide range of proteins, including nitrated proteins. J Neurochem 2003;86:363-73.